感覚受容体を除くGPCRをヒト 300種、マウス 250種、計550種取り揃え、共役するGαタンパク質のサブタイプに依らず単一フォーマットのアッセイで活性を評価します。 各受容体の詳細は表をクリックしてください。また、ラット、ウサギ、イヌ、カニクイザルなど他種のGPCRについてはお問い合わせください。

Species
Family
Panel
Download Catalog
Filters Sort results
Reset Apply
Species
Receptor
Family
Assays
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
à la carte
Reference agonist:
tyramine
EC50:
880 nM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Cardiology
Dermatology
Urology/Reproduction
à la carte
Reference agonist:
urotensin ⅠⅠ
EC50:
92 pM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Safety
Safety Premium
Psychiatry
Cardiology
Urology/Reproduction
à la carte
Reference agonist:
[R]‐vasopressin
EC50:
510 pM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Safety Premium
à la carte
Reference agonist:
[R]‐vasopressin
EC50:
840 pM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Safety Premium
Endocrinology/Metabolism
Cardiology
Musculoskeletal
Urology/Reproduction
à la carte
Reference agonist:
[R]‐vasopressin
EC50:
4.8 nM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Safety Premium
Psychiatry
Respiratory
à la carte
Reference agonist:
oxytocin
EC50:
1.9 nM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Immunology/Infection
Hematology
Psychiatry
Respiratory
à la carte
Reference agonist:
PACAP
EC50:
4.4 nM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Hematology
Gastrointestinal
à la carte
Reference agonist:
VIP
EC50:
2.7 nM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
Ophthalmology
à la carte
Reference agonist:
VIP
EC50:
13 nM
Human
Assay modes:
-
Panels:
-
Reference agonist:
EC50:
Human
Assay modes:
-
Panels:
-
Reference agonist:
EC50:
Human
Assay modes:
-
Panels:
-
Reference agonist:
EC50:
Human
Assay modes:
-
Panels:
-
Reference agonist:
EC50:
Human
Assay modes:
-
Panels:
-
Reference agonist:
EC50:
Human
Assay modes:
-
Panels:
-
Reference agonist:
EC50:
Human
Assay modes:
-
Panels:
-
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
à la carte
Reference agonist:
LPS
EC50:
240 nM
Human
Available
Assay modes:
Agonist
Inverse agonist
Antagonist
PAM
NAM
Panels:
Human non-orphan GPCRs
à la carte
Reference agonist:
LPS
EC50:
22 nM
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
zaprinast
EC50:
2.8 µM
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
Human
Available
Assay modes:
Agonist
Panels:
Human orphan GPCRs
à la carte
Reference agonist:
EC50:
145612

お問い合わせ

試験委託、見積依頼、共同研究のご提案、その他お問い合わせを賜ります。まずはアッセイ系について説明を受けたい、どのような試験デザインが可能か検討したい、といったご要望に応え、電話やウェブ会議での無料相談も行っています。以下のフォームかメールにてご連絡下さい。

試験委託の流れ

見積り依頼

ご希望、目的に適した試験と価格をご提案します。

STEP
1

発注

試験受委託契約を締結して頂きます。秘密保持契約も可能です。

STEP
2

化合物送付

当社宛に化合物をお送り頂きます。

STEP
3

報告書受領

試験開始から通常3週間後に結果報告書と生データを電子メールでお送りします。

STEP
4

お問い合わせフォーム